SCOPUS 정보 검색 플랫폼

Volumn 18, Issue 3, 2006, Pages 201-204

Neuroleptic malignant syndrome and serotonin syndrome in the critical care setting: Case analysis

(4) Kaufman, Kenneth R a Levitt, Michael J a Schiltz, John F a Sunderram, Jagadeeshan a

a ROBERT WOOD JOHNSON MEDICAL SCHOOL (United States)

Author keywords

Antidepressants; Antipsychotics; Bromocriptine; Carbamazepine; CPK; Cyproheptadine; Dantrolene; Divalproex sodium; Mortality; Neuroleptic malignant syndrome (NMS); Risperidone; Serotonin syndrome (SS); Topiramate; Venlafaxine

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; BROMOCRIPTINE; CARBAMAZEPINE; CHLORPROMAZINE; CREATINE KINASE; CYPROHEPTADINE; DANTROLENE; INFUSION FLUID; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE; SEROTONIN AGONIST; TOPIRAMATE; VALPROATE SEMISODIUM; VENLAFAXINE;

ADULT; ALGORITHM; ARTICLE; CASE REPORT; CLINICAL FEATURE; CREATINE KINASE BLOOD LEVEL; DIFFERENTIAL DIAGNOSIS; DRUG CONTRAINDICATION; DRUG HALF LIFE; DRUG OVERDOSE; DRUG WITHDRAWAL; EMERGENCY; FEMALE; HUMAN; INTENSIVE CARE; INTUBATION; LABORATORY TEST; NEUROLEPTIC MALIGNANT SYNDROME; PATIENT MONITORING; POLYPHARMACY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REHYDRATION; SEROTONIN SYNDROME;

ADULT; ANTICONVULSANTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; BROMOCRIPTINE; CARBAMAZEPINE; COMORBIDITY; CREATINE KINASE; CRITICAL CARE; CYPROHEPTADINE; DANTROLENE; DIAGNOSIS, DIFFERENTIAL; DRUG INTERACTIONS; FEMALE; FRUCTOSE; HUMANS; NEUROLEPTIC MALIGNANT SYNDROME; OVERDOSE; RISPERIDONE; SEROTONIN SYNDROME; SEROTONIN UPTAKE INHIBITORS; VALPROIC ACID;

EID: 33750083633 PISSN: 10401237 EISSN: 15473325 Source Type: Journal
DOI: 10.1080/10401230600801259 Document Type: Article

Times cited : (29)

References (20)

1
- 0033856331
- Serotonin syndrome. Presentation of 2 cases and review of the literature
- Mason PJ, Morris VA, Balcezak TJ: Serotonin syndrome. Presentation of 2 cases and review of the literature. Medicine (Baltimore) 2000; 79:201-209
- (2000) Medicine (Baltimore) , vol.79 , pp. 201-209
- Mason, P.J.¹ Morris, V.A.² Balcezak, T.J.³

2
- 0037317286
- Serotonin syndrome induced by low-dose venlafaxine
- Pan, JJ, Shen, WW: Serotonin syndrome induced by low-dose venlafaxine. Ann Pharmacother 2003; 37:209-211
- (2003) Ann Pharmacother , vol.37 , pp. 209-211
- Pan, J.J.¹ Shen, W.W.²

3
- 0037527655
- Serotonin syndrome: A brief review
- Birmes P, Coppin D, Schmitt L, Lauque D: Serotonin syndrome: A brief review. CMAJ 2003; 168:1439-1442
- (2003) CMAJ , vol.168 , pp. 1439-1442
- Birmes, P.¹ Coppin, D.² Schmitt, L.³ Lauque, D.⁴

4
- 0029926503
- Serotonin syndrome
- Martin, TG: Serotonin syndrome. Ann Emerg Med 1996; 28:520-526
- (1996) Ann Emerg Med , vol.28 , pp. 520-526
- Martin, T.G.¹

5
- 0025869797
- The serotonin syndrome
- Sternbach H: The serotonin syndrome. Am J Psychiatry 1991; 148:705-713
- (1991) Am J Psychiatry , vol.148 , pp. 705-713
- Sternbach, H.¹

6
- 0030862983
- Serotonin syndrome: A clinical update
- Mills KC: Serotonin syndrome: a clinical update. Crit Care Clin 1997; 13:763-783
- (1997) Crit Care Clin , vol.13 , pp. 763-783
- Mills, K.C.¹

7
- 0027390148
- The central nervous system serotonin syndrome
- Nierenberg DW, Semprebon M: The central nervous system serotonin syndrome. Clin Pharmacol Ther 1993; 53:84-88
- (1993) Clin Pharmacol Ther , vol.53 , pp. 84-88
- Nierenberg, D.W.¹ Semprebon, M.²

8
- 0034921319
- Serotonin syndrome: Early management with cyproheptadine
- McDaniel WW: Serotonin syndrome: Early management with cyproheptadine. Ann Pharmacother 2001; 35:870-873
- (2001) Ann Pharmacother , vol.35 , pp. 870-873
- McDaniel, W.W.¹

9
- 0030993405
- Serotonin syndrome treated with chlorpromazine
- Gillman, PK: Serotonin syndrome treated with chlorpromazine. J Clin Psychopharmacol 1997; 17:128-129
- (1997) J Clin Psychopharmacol , vol.17 , pp. 128-129
- Gillman, P.K.¹

10
- 0032999945
- The serotonin syndrome and its treatment
- Gillman, PK: The serotonin syndrome and its treatment. J Psychopharmacol 1999; 13:100-109
- (1999) J Psychopharmacol , vol.13 , pp. 100-109
- Gillman, P.K.¹

11
- 0034127738
- The neuroleptic malignant and serotonin syndromes
- Carbone JR: The neuroleptic malignant and serotonin syndromes. Emerg Med Clin North Am 2000; 18:317-325
- (2000) Emerg Med Clin North Am , vol.18 , pp. 317-325
- Carbone, J.R.¹

12
- 0023388250
- Metoclopramide-induced neuroleptic malignant syndrome
- Friedman LS, Weinrauch LA, D'Elia JA: Metoclopramide-induced neuroleptic malignant syndrome. Arch Intern Med 1987; 147:1495-1497
- (1987) Arch Intern Med , vol.147 , pp. 1495-1497
- Friedman, L.S.¹ Weinrauch, L.A.² D'Elia, J.A.³

13
- 0027531002
- Neuroleptic malignant syndrome
- Caroff SN, Mann SC: Neuroleptic malignant syndrome. Med Clin North Am 1993; 77:185-202
- (1993) Med Clin North Am , vol.77 , pp. 185-202
- Caroff, S.N.¹ Mann, S.C.²

14
- 0024494998
- Mortality from neuroleptic malignant syndrome
- Shalev A, Hermesh H, Munitz, H: Mortality from neuroleptic malignant syndrome. J Clin Psychiatry 1989; 50:18-25
- (1989) J Clin Psychiatry , vol.50 , pp. 18-25
- Shalev, A.¹ Hermesh, H.² Munitz, H.³

15
- 0025997443
- Drug treatment of neuroleptic malignant syndrome
- Sakkas P, Davis JM, Janicak PG, Wang ZY: Drug treatment of neuroleptic malignant syndrome. Psychopharmacol Bull 1991; 27:381-384
- (1991) Psychopharmacol Bull , vol.27 , pp. 381-384
- Sakkas, P.¹ Davis, J.M.² Janicak, P.G.³ Wang, Z.Y.⁴

16
- 0024399916
- Serotonin syndrome versus neuroleptic malignant syndrome as a cause of death
- Kline SS, Mauro LS, Scala-Barnett DM, Zick D: Serotonin syndrome versus neuroleptic malignant syndrome as a cause of death. Clin Pharm 1989; 8:510-514
- (1989) Clin Pharm , vol.8 , pp. 510-514
- Kline, S.S.¹ Mauro, L.S.² Scala-Barnett, D.M.³ Zick, D.⁴

17
- 0004235298
- American Psychiatric Association: Washington, DC: American Psychiatric Association
- American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994
- (1994) Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition

18
- 0035933079
- Effect of L-carnitine treatment for valproate-induced hepatotoxicity
- Bohan TP, Helton E, McDonald I, Konig S, Gazitt S, Sugimoto T, Scheffner D, Cusmano L, Li S, Koch G: Effect of L-carnitine treatment for valproate-induced hepatotoxicity. Neurology 2001; 56:1405-1409
- (2001) Neurology , vol.56 , pp. 1405-1409
- Bohan, T.P.¹ Helton, E.² McDonald, I.³ Konig, S.⁴ Gazitt, S.⁵ Sugimoto, T.⁶ Scheffner, D.⁷ Cusmano, L.⁸ Li, S.⁹ Koch, G.¹⁰

19
- 0036110770
- High serum creatinine kinase level: Possible risk factor for neuroleptic malignant syndrome
- Hermesh H, Manor I, Shiloh R, Aizenberg D, Benjamini Y, Munitz H, Weizman A: High serum creatinine kinase level: Possible risk factor for neuroleptic malignant syndrome. J Clin Psychopharmacol 2002; 22:252-256
- (2002) J Clin Psychopharmacol , vol.22 , pp. 252-256
- Hermesh, H.¹ Manor, I.² Shiloh, R.³ Aizenberg, D.⁴ Benjamini, Y.⁵ Munitz, H.⁶ Weizman, A.⁷

20
- 15044361698
- The serotonin syndrome
- Boyer EW, Shannon M: The serotonin syndrome. NEJM 2005; 352:1112-1120
- (2005) NEJM , vol.352 , pp. 1112-1120
- Boyer, E.W.¹ Shannon, M.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.